Mechanisms of trastuzumab resistance and their clinical implications

被引：60
|
作者：
Lan, KH
Lu, CH
Yu, DH
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
来源：
TUMOR PROGRESSION AND THERAPEUTIC RESISTANCE | 2005年 / 1059卷
关键词：
trastuzumab; resistance; ErbB2; breast cancer; PI3K; PTEN;
D O I：
10.1196/annals.1339.026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Trastuzumab (Herceptin"') is an excellent model of rationally designed targeted cancer treatment. However, less than 35% of patients with ErbB2-positive breast tumors respond to trastuzumab as a single agent, and 2-5% of trastuzumab-treated patients suffer from severe side effects, including cardiac dysfunction. Recent progress in understanding the mechanisms of trastuzumab antitumor function and cellular defects leading to trastuzumab resistance is summarized. Also explored is the potential of combination therapies for reversing trastuzumab resistance.
引用
收藏
页码：70 / 75
页数：6
相关论文
共 50 条
  • [1] Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond
    Garcia-Alonso, Sara
    Ocana, Alberto
    Pandiella, Atanasio
    TRENDS IN CANCER, 2020, 6 (02): : 130 - 146
  • [2] Clinical resistance to imatinib: mechanisms and implications
    Hochhaus, A
    Hughes, T
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (03) : 641 - +
  • [3] Resistance mechanisms and prospects of trastuzumab
    Wang, Lizhe
    Wang, Yu
    Li, Yueyang
    Zhou, Li
    Du, Jiahui
    Wang, Jin
    Liu, Sihan
    Cao, Yongyi
    Li, Yuzhi
    Yang, Wenying
    Zhu, Ting
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [4] Clinical implications of mechanisms of resistance to antiepileptic drugs
    Alvarez, Juan Carlos Sanchez
    Castro, Pedro J. Serrano
    Fernandez, Jose Maria Serratosa
    NEUROLOGIST, 2007, 13 (06) : S38 - S46
  • [5] Aspirin Resistance: Detection, Mechanisms and Clinical Implications
    Linden, Matthew D.
    Frelinger, A. L., III
    Przyklenk, Karin
    Furman, Mark I.
    Michelson, Alan D.
    CURRENT CARDIOLOGY REVIEWS, 2005, 1 (03) : 203 - 211
  • [6] Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications
    Iredell, Jon
    Brown, Jeremy
    Tagg, Kaitlin
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
  • [7] Antiviral Drug Resistance: Mechanisms and Clinical Implications
    Strasfeld, Lynne
    Chou, Sunwen
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2010, 24 (02) : 413 - +
  • [8] Trastuzumab: Mechanisms of Resistance and Therapeutic Opportunities
    Calabrich, Aknar
    Fernandes, Gustavo Dos Santos
    Katz, Artur
    ONCOLOGY-NEW YORK, 2008, 22 (11): : 1250 - 1258
  • [9] Mechanisms of Trastuzumab Resistance in Breast Cancer
    Tolaney, Sara M.
    Krop, Ian E.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (03) : 348 - 355
  • [10] RESISTANCE TO CISPLATIN AND ANALOGS - MECHANISMS AND POTENTIAL CLINICAL IMPLICATIONS
    DEGRAEFF, A
    SLEBOS, RJC
    RODENHUIS, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (04) : 325 - 332
12345